BALYASNY ASSET MANAGEMENT L.P. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$80,585
+41.4%
90,954
+152.0%
0.00%
Q3 2022$57,000
-54.0%
36,094
-41.3%
0.00%
Q2 2022$124,000
+93.8%
61,446
+345.1%
0.00%
Q4 2021$64,000
-49.2%
13,805
-9.6%
0.00%
-100.0%
Q1 2021$126,000
-12.5%
15,266
-27.8%
0.00%0.0%
Q4 2020$144,000
-68.3%
21,130
-79.5%
0.00%
-50.0%
Q3 2018$454,000103,2520.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,799,790$11,059,0003.50%
Intellectus Partners, LLC 1,095,840$4,329,0002.20%
Cormorant Asset Management, LP 1,690,800$6,679,0000.97%
Avoro Capital Advisors LLC 1,192,130$4,709,0000.60%
Vident Investment Advisory, LLC 170,534$674,0000.07%
GAGNON SECURITIES LLC 11,116$44,0000.02%
MATRIX ASSET ADVISORS INC/NY 22,000$87,0000.02%
R&F Capital Advisors LP 12,878$51,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 96,154$380,0000.01%
Virtu KCG Holdings LLC 27,425$108,0000.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders